SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 7, 2000
OSTEOTECH, INC.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-19278 13-3357370
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission file Number) (IRS Identification No.)
of incorporation)
51 James Way, Eatontown, New Jersey 07724
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (732) 542-2800
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
On June 7, 2000, Osteotech, Inc. announced that it had entered into an exclusive
five-year processing agreement with Bone Bank Allografts ("BBA") of San Antonio,
Texas. BBA, which is an accredited tissue bank by the American Association of
Tissue Banks, coordinates the procurement and distribution of allograft bone
tissue nationally, with a focus in the South. BBA was organized in 1991 by Joe
and D'Lynn Mims.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: June 13, 2000
OSTEOTECH, INC.
--------------------------------
(Registrant)
By: /s/ Michael J. Jeffries
--------------------------------
MICHAEL J. JEFFRIES
Executive Vice President,
Chief Financial Officer
(Principal Financial Officer
and Principal Accounting Officer)
